Sterling expands in North Carolina

Following on from earlier acquisitions and investments on both sides of the Atlantic, Sterling Pharma Solutions has commenced a $2.1 million expansion project to increase chemical and analytical capabilities at its facility in Cary, North Carolina. The work should be completed by the end of 2022 and will create up to 20 new jobs. This will include five new laboratories: two for R&D, one for scaling up chemical synthesis and others for QC and analytical services.

The 2,500 m2 facility opened in 1994 and employs 50. It provides services to support API development and manufacturing product from pre-clinical through to Phase 2, including cGMP manufacturing, and capabilities to handle DEA schedule 1-5 controlled substances.